China Innovation, Large Market Continue To Lure Foreign Investment

Robust Activity Despite De-Risking

Investment and potential growth
Global biopharmas expand their investments in manufacturing upgrade and biotech innovation in China (Shutterstock)

More from Scrip

More from Business